• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Malaria News / World Health Organization Seeks Funding for Emergency Response to Drug-resistant Malaria

World Health Organization Seeks Funding for Emergency Response to Drug-resistant Malaria

October 27, 2013 By Steve Herman Leave a Comment

BANGKOK — The World Health Organization is warning that about $450 million is needed over the next three years to stop a strain of drug-resistant malaria from spreading beyond Southeast Asia to the rest of the world.

Researchers say the artemisinin-resistant strain has spread to Burma and Vietnam since it was first detected along the Cambodian-Thai border in 2008. In addition to sounding the alarm about drug-resistant malaria, the World Health Organization is rolling out an emergency response to what it terms a potentially serious global health threat.

The first line of defense against the deadliest strain of malaria, treatment based on artemisinin medication, is failing. WHO team leader Eva-Maria Christophel in Manila says the organization is now ensuring sufficient surveillance has been put in place in the areas around the strain’s origin in the Greater Mekong sub-region.

“All countries in the Asia-Pacific region are able to really monitor, at a high quality, the drug-resistance situation in their countries so that we really know whether there are further problems somewhere else. And, then, if discovered then similar containment responses must be launched,” said Christophel.

Christophel says communities where an outbreak is detected will get special attention. “They will see a quite significant amount of malaria control and elimination activities being rolled out which both cover diagnosis and treatment, cover the preventive part in terms of bed nets. In some countries, also indoor residual sprayings and health education for malaria so that people really know what this all about and how they can protect themselves,” said Christophel.

Most at risk are villagers living on the fringes of forests, a favorite habitat of the mosquitoes which transmit Plasmodium faciparum, a protozoan parasite, to humans. A three-day dose of the drug artemisinin, combined with other medications, can kill most of the parasites. The WHO says resistance to artemisinin may have been caused by the parasite’s long exposure to the drug, as well as the use of substandard or counterfeit medications in Asia and Africa. WHO says a pledge of $100 million to fight the spread of drug-resistant malaria has been given by the Swiss-based Global Fund to Fight AIDS, Tuberculosis and Malaria. But a funding gap of $450 million still remains.

Source: VOA
A veteran journalist, Steven L. Herman is the Voice of America Asia correspondent.

Filed Under: Malaria News Tagged With: Artemisinin, Burma, Eva-Maria Christophel, Vietnam, World Health Organization (WHO)

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2023 Malaria.com · Log in